0001209191-22-034919.txt : 20220607
0001209191-22-034919.hdr.sgml : 20220607
20220607200013
ACCESSION NUMBER: 0001209191-22-034919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220606
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kropotova Alexandra
CENTRAL INDEX KEY: 0001825323
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39871
FILM NUMBER: 221002335
MAIL ADDRESS:
STREET 1: RIVER OAKS TOWER
STREET 2: 8800 HSC PARKWAY
CITY: BYRAN
STATE: TX
ZIP: 77807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001833214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 853899721
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 EAST 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57104
BUSINESS PHONE: 605-679-6980
MAIL ADDRESS:
STREET 1: 2100 EAST 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57104
FORMER COMPANY:
FORMER CONFORMED NAME: Big Cypress Acquisition Corp.
DATE OF NAME CHANGE: 20201120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-06
0
0001833214
SAB Biotherapeutics, Inc.
SABS
0001825323
Kropotova Alexandra
2100 EAST 54TH STREET NORTH
SIOUX FALLS
SD
57104
0
1
0
0
Chief Medical Officer
Common Stock
2022-06-06
4
A
0
300000
0.00
A
300000
D
Restricted Stock Unit ("RSU") award under the 2021 Equity Incentive Plan, which vests over a four-year service period, with the first 25% vesting on June 6, 2023, and the remaining vesting in even monthly increments thereafter. The RSU award is subject to the reporting person's continued employment through the vesting date.
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
/s/ Alexandra Kropotova
2022-06-07